OLPREZIDE

Medicinal product

(Invented) name

OLPREZIDE

Active substance (s)

Olmesartanas medoksomilis/Hidrochlorotiazidas

Strength

40 mg/12,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C09DA08, Olmesartan medoxomil and diuretics

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-08-13

Date of renewal

Documents

2770_OLPREZIDE 40 mg12,5 mg plėv dengt tabl_PZ_2025-08-13.docx

2770_OLPREZIDE 40 mg12,5 mg plėv dengt tabl_PL_2025-08-13.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Olmesartanas medoksomilis	40 mg
Hidrochlorotiazidas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118319	104424	1104424	lizdinė plokštelė	N28		Receptinis	LT/L/25/2770/001	Netiekiama	-	2026-01-01	No	-	-	Download

Stadijos

Data	Stadija
2025-08-13	Registruotas